Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

Global (Non-US) Healthcare IT Trends 2024
|
2024
Global (Non-US) Healthcare IT Trends 2023
|
2023

 End chart zoom
Global HIT Trends 2015 Global HIT Trends 2015
* A page refresh may be necessary to see the updated image

Global HIT Trends 2015
Which Vendors Are Providers Betting On?

author - Jeremy Goff
Author
Jeremy Goff
author - Jonathan Christensen
Author
Jonathan Christensen
 
December 9, 2015 | Read Time: 2  minutes

Providers globally are focused on adopting and upgrading EMR solutions at a higher rate than ever before. Those tasked with making the choice want to know which vendors are considered in their region and what sets those vendors apart. KLAS interviewed key decision makers at 111 organizations around the globe to understand their buying plans. Of these organizations, 46 plan to replace or acquire a new EMR. Additionally, providers shared their purchasing plans for other technologies, such as imaging, analytics, and enterprise content management solutions.

1. CERNER MOST WIDELY CONSIDERED EMR; EPIC NOT FAR BEHIND

Providers outside the U.S. seriously consider Cerner more than any other EMR vendor due to their large global footprint, strong functionality, and flexibility in contracting and implementation. More providers are strongly considering Epic than in the past thanks to Epic’s functionality, big-bang implementation methodology, and strong customer partnerships. Large organizations (>1,000 beds) consider Cerner and Epic the most. InterSystems and Allscripts considerations have nearly doubled since last year: InterSystems’ comprehensive functionality, fast implementations, and competitive pricing resonate with providers, whereas Allscripts has capitalized on their existing footprint in the UK.

globally considered emrs and likelihood to purchase

2. UK INTEREST IN ALLSCRIPTS GROWS; EPIC LEADS IN MAINLAND EUROPE

While Cerner is still the most considered vendor, UK providers mention Allscripts as a serious option nearly half the time, pointing to a lower overall price point and the vendor’s momentum in Northwest England. UK considerations for Epic and CSC Lorenzo are headed in the opposite direction. Epic’s higher cost and CSC’s functionality gaps are concerning to providers. In mainland Europe, Epic has top consideration for their high performance and reputation. Providers also look to Cerner and ChipSoft outside the UK thanks to their established presence.

european emr trends

3. MULTIREGIONAL PLAYERS OVERSHADOWING REGIONAL PLAYERS

Providers in most other regions are looking to larger multiregional players like Cerner, Epic, InterSystems, and Allscripts as reliable EMR options due to the vendors’ track records and large pools of available resources. This is not the case in the Brazilian EMR market, where locally developed products from MV Sistemas and Philips are always considered. Based on signed 2014 contracts (not included in this research), MV Sistemas and Philips are almost always selected over these higher-cost, multiregional solutions.

regional emr considerations

4. GE & CARESTREAM MOST CONSIDERED PACS; AGFA & GE MOST REPLACED

beyond emr

Though nonscientific in nature, the chart above shows the top-searched market segments on KLAS’ website thus far in 2015. Due to provider interest in the PACS segment, KLAS dug deeper to find out which PACS vendors are being considered and which are being replaced.

author - Emily Paxman
Writer
Emily Paxman
author - Natalie Jamison
Designer
Natalie Jamison
author - Robert Ellis
Project Manager
Robert Ellis
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

​